Physician profile
Tami Biesenthal
NPI 1346469756
$950.10
in general payments reported to CMS, 2019-2025
13 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.66 · 2022: $68.75 · 2023: $159 · 2024: $332 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $207.13 | 2022-2024 | Myrisk, Bracanalysis Cdx |
| Merck Sharp & Dohme LLC | $153.02 | 2021-2025 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals Lp | $127.91 | 2021-2025 | Lynparza |
| Caris Mpi, INC. | $87.04 | 2025 | Mi Cancer Seek |
| Glaxosmithkline, LLC. | $81.31 | 2024 | |
| Ethicon US, LLC | $57.97 | 2022-2024 | Vistaseal, Surgicel Nu-Knit |
| Abbvie INC. | $54.62 | 2024 | |
| Tempus Ai, INC | $50.21 | 2025 | Xt Cdx |
| Eisai INC. | $40.98 | 2024-2025 | |
| Integra Lifesciences Corporation | $34.13 | 2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Certas |
| Fennec Pharmaceuticals, INC. | $22.30 | 2025 | Fyarro |
| Tactile Systems Technology INC | $16.92 | 2025 | Nimbl, Flexitouch Plus |
| Therapeuticsmd, INC. | $16.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tami Biesenthal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.